Althea's strategic role as an industry catalyst to enable the full potential of targeted therapeutics via population-specific diagnostics for early detection and continuous monitoring of disease is realized through our exclusive Express Pathway program. Express Pathway provides resources to access characterized samples for |
validation and testing of highly differentiated diagnostic signatures, developed with in-house technologies such as XP(TM)-PCR, and made commercially available on proven platforms that can perform tests routinely. |
